Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676793 · ClinicalTrials.gov registry record · Phase 2
A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
A Phase 2 study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT00676793 is a Phase 2 study that has completed, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 32 participants.
The verdict
NCT00676793, a Phase 2 study, has completed, sponsored by Louisiana State University Health Sciences Center Shreveport.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
To see if an extract of green tea can affect certain markers of breast cancer and breast cancer progression in women with a recent biopsy positive for cancer and who are scheduled for surgery.
Interventions
- DRUG Polyphenon E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2004-05 |
| Est. Completion | 2013-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00676793
The ClinicalTrials.gov registry entry for NCT00676793 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center Shreveport, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Polyphenon E is the first listed.
NCT00676793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00676793 about?
NCT00676793 is a clinical study titled "A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression". To see if an extract of green tea can affect certain markers of breast cancer and breast cancer progression in women with a recent biopsy positive for cancer and who are scheduled for surgery.
What is the current status of trial NCT00676793?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2004-05. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00676793?
The interventions under investigation include: Polyphenon E (DRUG).
Who is sponsoring clinical trial NCT00676793?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.